Skip to main content
. 2012 Feb;167(2):330–337. doi: 10.1111/j.1365-2249.2011.04504.x

Fig. 2.

Fig. 2

Interstitial fibrosis in graft biopsies from kidney transplant recipients (KTR) under belatacept or cyclosporin A (CsA) treatment. Pre-implantation: n = 36 biopsies; belatacept: n = 27 biopsies (only 15 samples had their corresponding pre-implantation biopsy); CsA: n = 9 biopsies (only eight samples had their corresponding pre-implantation biopsy). Results are expressed as mean ± standard error.